The Wall Street Journal
The Wall Street Journal
@wsj·6.6M subscribers·28.9K videos

Merck’s New Covid-19 Pill: Molnupiravir, Explained

Posted

October 13, 2021

Views

16,271

Likes

361

Comments

73

Engagement

2.67%

Search the Record

Indexed

Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.

Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.

Try a name, a topic, or a quoted line

YouTube Description

as posted by the channel

After almost two years, there’s a new, easy-to-take Covid-19 pill treatment. Merck’s molnupiravir drug could be available as soon as the end of the year if it gets authorized by the FDA. It would help make Covid-19 a more manageable disease, marking a pivotal turning point in the pandemic.

#Molnupiravir #CovidPill #DanielaHernandez

Guests & Subjects Covered

Merck’s New Covid-19 PillFDA ItMolnupiravir CovidPill DanielaHernandez

Sentinel Indexing in Progress

Metadata and chapters are available. Claim extraction for this episode is pending.

All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.